METTL3 also enhances the expression and stability of LINC00958, which targets miR-3619-5p to upregulate hepatocellular carcinoma-derived growth factors, thereby promoting HCC lipogenesis and progression [73]. Here, METTL3 is linked to hepatocellular carcinoma.